CMT Research Foundation – Apply for Funding for CMT Research (2025–2026 Deadlines)

Apply for research funding from the CMT Research Foundation to advance therapies and cures for Charcot-Marie-Tooth disease. Global researchers, clinicians, and biotech companies are eligible.

---

CMT Research Foundation – Apply for Funding for CMT Research

The CMT Research Foundation (CMTRF) is dedicated to finding treatments and cures for Charcot-Marie-Tooth disease (CMT) within our lifetime. Through targeted and strategic funding, the foundation supports the most promising scientific projects that aim to translate discoveries into real-world therapeutic solutions for all CMT types.

Founded with a clear mission to bridge the gap between laboratory science and patient impact, CMTRF works with leading researchers, universities, and biotech companies worldwide. Its funding model emphasizes collaboration, innovation, and measurable progress toward developing CMT therapies.

---

Funding Overview

The CMT Research Foundation welcomes applications from researchers and organizations pursuing approaches that align with its mission. While the foundation prioritizes projects based on its research agenda, creative and high-potential ideas are also considered.

Key Funding Details

• Average Award Amount: USD 100,000 – 200,000 per year (larger budgets considered for exceptional proposals)

• Award Duration: 1–3 years, with the possibility of follow-on funding

• Eligible Applicants:

  • Academic institutions and medical research centers

  • Non-profit and for-profit research organizations

  • Biotechnology companies with an interest in CMT therapeutics

Funding may be provided to for-profit organizations when their projects align with CMTRF’s mission. Co-funding and cost-sharing with other agencies, investors, or industry partners are highly encouraged.

Eligible Research Areas

The foundation supports projects addressing:

• Therapeutic development for all CMT subtypes

• Translational studies that advance preclinical or clinical readiness

• Collaborative models bridging academia and industry

Learn more about CMTRF’s approach and research priorities on their official website.

---

Application Deadlines and Process

Before submitting a full proposal, applicants must first submit a Letter of Intent (LOI). Invitations to submit a full proposal are typically issued three weeks after LOI submission, allowing time to refine the application based on feedback from the CMTRF Scientific Advisory Board (SAB).

Applicants are strongly encouraged to submit the LOI early to allow ample time for revisions and proposal preparation.

Quarterly Submission Deadlines (2025–2026):

• Q1: December 17, 2025

• Q2: February 18, 2026

• Q3: May 20, 2026

• Q4: August 12, 2026

LOIs submitted less than six weeks before these deadlines may be deferred to the following cycle at CMTRF’s discretion.

Application Steps

1. Letter of Intent (LOI)

Submit a 1–2 page PDF highlighting:

• Project aims and expected milestones

• Potential collaborations or co-funding arrangements

• Alignment with CMTRF’s mission and strategic goals

Submit your Letter of Intent via the online portal:
Submit LOI Here

2. Full Proposal

Upon invitation, applicants must prepare a detailed proposal (PDF format) including:

• Lay Summary and Scientific Rationale

• Specific Aims and Background

• Preliminary Data and Experimental Plan

• Detailed Budget and Justification

• Gantt Chart of Proposed Work

• NIH Biosketches and Other Support documents

Feedback is typically provided within 3–8 weeks after submission.

Indirect costs are capped at 10%.

---

Emerging Researcher Award

To stimulate early-stage innovation, the Emerging Researcher Award provides smaller, high-impact grants targeting key barriers in CMT drug development.

Two funding tracks are available:

• Predoctoral Grants: Open to current PhD or MD students conducting CMT research.

• Pilot Grants: Open to postdoctoral fellows and early-career investigators in academia or industry.

This program supports promising young scientists in producing preliminary data that can lead to larger CMT-focused projects. Collaborative efforts between academic and industry partners are strongly encouraged.

For full details, visit the Emerging Researcher Award page.

---

Review Process and Evaluation

The CMT Research Foundation employs an iterative application process, allowing applicants to receive constructive feedback from CMT and industry experts. This approach ensures that every funded project has a clear path to translational or clinical impact.

Proposals are reviewed by the Scientific Advisory Board (SAB), which evaluates:

• Scientific and therapeutic relevance

• Feasibility and innovation

• Research milestones and impact potential

• Collaboration with industry or cross-institutional partners

---

Funding Terms and Reporting

All funding decisions are contingent on the successful negotiation of contract terms between CMTRF and the awardee institution. Progress is tracked against milestone-based deliverables, and continuation of funding depends on satisfactory performance and data outcomes.

Awardees must submit periodic progress and financial reports, ensuring accountability and alignment with the foundation’s mission.

Indirect costs up to 10% are permitted within the total project budget.

---

Contact Information

For program-related inquiries or questions about application requirements, contact:
Kate Andersh
Email: kate.andersh@cmtrf.org

To stay updated on future funding rounds and news, visit: https://cmtrf.org

---

How to Apply

Researchers and organizations interested in applying should:

1. Prepare and submit a Letter of Intent via the online portal as early as possible.

2. Upon invitation, develop a Full Proposal including all required sections and supporting materials.

3. Submit before one of the quarterly deadlines listed above.

Apply Now:

Access the portal here 

Deadline: Apply as soon as possible (upcoming round closes December 17, 2025).

---

Why Apply

The CMT Research Foundation provides a unique opportunity to secure high-impact funding for innovative research with tangible patient outcomes. By fostering collaboration between academia, biotech, and clinical experts, CMTRF accelerates the discovery of therapies that can transform lives.

If your research has the potential to advance CMT treatment, this program offers both funding and expert guidance to help you translate ideas into impact.

---

For more international career opportunities, visit Opportunities For Youth.